Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) and Nutex Health (NASDAQ:NUTX – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, valuation, institutional ownership, earnings and dividends.
Volatility & Risk
Guardian Pharmacy Services has a beta of 0.06, indicating that its stock price is 94% less volatile than the S&P 500. Comparatively, Nutex Health has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings for Guardian Pharmacy Services and Nutex Health, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Guardian Pharmacy Services | 0 | 1 | 9 | 0 | 2.90 |
| Nutex Health | 0 | 2 | 3 | 0 | 2.60 |
Guardian Pharmacy Services presently has a consensus price target of $45.57, indicating a potential downside of 2.47%. Nutex Health has a consensus price target of $342.00, indicating a potential upside of 110.98%. Given Nutex Health’s higher probable upside, analysts clearly believe Nutex Health is more favorable than Guardian Pharmacy Services.
Valuation and Earnings
This table compares Guardian Pharmacy Services and Nutex Health”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Guardian Pharmacy Services | $1.45 billion | 2.04 | $49.22 million | $1.17 | 39.94 |
| Nutex Health | $875.26 million | 1.27 | $70.79 million | $23.42 | 6.92 |
Nutex Health has lower revenue, but higher earnings than Guardian Pharmacy Services. Nutex Health is trading at a lower price-to-earnings ratio than Guardian Pharmacy Services, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Guardian Pharmacy Services and Nutex Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Guardian Pharmacy Services | 5.13% | 30.29% | 16.86% |
| Nutex Health | 20.68% | 34.43% | 17.01% |
Insider & Institutional Ownership
5.3% of Nutex Health shares are held by institutional investors. 33.0% of Guardian Pharmacy Services shares are held by insiders. Comparatively, 44.7% of Nutex Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Nutex Health beats Guardian Pharmacy Services on 9 of the 14 factors compared between the two stocks.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents’ medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.
About Nutex Health
Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company’s chairman and chief executive officer, Nutex operates in the United States.
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
